Modi Ventures — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

General Proximitygeneralproximity.bio in 𝕏Jan 2025

General Proximity develops proximity-based technologies for drug discovery and development.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

Armand Cognetta(Founder)inMatthias PauthnerCorentine Laurin(Principal Scientist, Medicinal Chemistry)Veronica Fulton(Chief of Staff)Benji Dote(EA)Reen Ramos(EA)

Co-investorsY Combinator age1 Felicis Ventures Freemind Investments Lifespan Vision Ventures Mana Ventures +3 more

Ignota Labsignotalabs.ai inFeb 2025

Ignota Labs uses SAFEPATH, a proprietary AI platform combining machine learning with bioinformatics and cheminformatics data, to identify and resolve drug safety and toxicity problems.

AI & Machine LearningBiotechDeep Tech

Jordan Lane(Founder)Sam Windsor(Founder)

Co-investorsAIX Ventures Blue Wire Capital Electric Feel Ventures Llc Gaingels Montage Ventures Sustainable Ventures

kamaukamautx.com in 𝕏May 2025

Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases.

BiotechDeep TechHealthtechAustin, US

Matthew Porteus(Executive Officer, Director)Valentin Barsan(Executive Officer, Director)

BoardRaymond Kelleher(Director)Ness Bermingham(Director)

Co-investorsDraper Associates Khosla Ventures Neva Sgr.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.